Advertisement

Header Utility Menu

  • Subscribe
  • Advertise
  • Contact Us
  • Events

LinkedIn Facebook Twitter Instagram Get Our App

  • Login

Virginia Business

Mobile Menu

  • Issues
  • Industries
    • Banking/Finances
    • Law
    • Real Estate
    • Economic Development
    • Education
    • Energy/Green
    • Federal Contracting
    • Government
    • Healthcare
    • Hotels/Tourism
    • Insurance
    • Ports/Trade
    • Small Business
    • Startups
    • Technology
    • Transportation
  • Regions
    • Central Virginia
    • Eastern Virginia
    • Northern Virginia
    • Roanoke/New River Valley
    • Shenandoah Valley
    • Southern Virginia
    • Southwest Virginia
  • Reports
    • Best Places to Work
    • Business Person of the Year
    • CEO Pay
    • COVID-19
    • Generous Virginians Project
    • Legal Elite
    • Most Influential Virginians
    • Maritime Guide
    • Site Locator
    • The Big Book
    • Virginia CFO Awards
  • Company News
    • For the Record
    • People
  • Opinion
  • Lists
  • Awards/Events
    • 2022 Virginia Business Political Roundtable
    • Women in Leadership
    • Diversity Leadership Series
    • Virginia 500
    • Legal Elite
    • CFO Awards
    • Big Book of Lists
    • 100 People To Meet
    • Best Places To Work
  • Virginia 500
    • Read The Issue
    • Power Up Virginia 500
    • Buy an award plaque
    • Suggest execs for 2023

Advertisement

Header Primary Menu

  • Issues
    • February 2023
    • January 2023
    • December 2022
    • November 2022
    • October 2022
    • Issues Archive
  • Industries
    • Banking/Finances
    • Law
    • Real Estate
    • Economic Development
    • Education
    • Energy/Green
    • Federal Contracting
    • Government
    • Healthcare
    • Hotels/Tourism
    • Insurance
    • Ports/Trade
    • Small Business
    • Startups
    • Technology
    • Transportation
  • Regions
    • Central Virginia
    • Eastern Virginia
    • Northern Virginia
    • Roanoke/New River Valley
    • Shenandoah Valley
    • Southern Virginia
    • Southwest Virginia
  • Reports
    • Best Places to Work
    • Business Person of the Year
    • CEO Pay
    • COVID-19
    • Generous Virginians Project
    • Legal Elite
    • Most Influential Virginians
    • Maritime Guide
    • Site Locator
    • The Big Book
    • Virginia CFO Awards
  • Company News
    • For the Record
    • People
  • Opinion
  • Lists
  • Awards/Events
    • 2022 Virginia Business Political Roundtable
    • Women in Leadership
    • Diversity Leadership Series
    • Virginia 500
    • Legal Elite
    • CFO Awards
    • Big Book of Lists
    • 100 People To Meet
    • Best Places To Work
  • Virginia 500
    • Read The Issue
    • Power Up Virginia 500
    • Buy an award plaque
    • Suggest execs for 2023

Home News Industries Healthcare J&J vaccine put on pause in Va. due to safety concerns

J&J vaccine put on pause in Va. due to safety concerns

Va. woman died in March after receiving vaccine, but officials have not confirmed connection

Published April 13, 2021 by Kate Andrews

vaccine
Photo courtesy VCU Capital News Service. (Photo credit: Art Writ)

Updated 6:30 p.m. April 13: Virginia health officials say the CDC has confirmed the Virginia woman’s death is connected to their call earlier Tuesday for a pause on use of the Johnson & Johnson vaccine.

Earlier:

On Tuesday, the Virginia Department of Health immediately put a pause on its use of the Johnson & Johnson single-dose COVID-19 vaccine as federal health agencies recommended halting use of the Johnson & Johnson vaccine while they examine safety issues, including rare blood clots. According to federal data, a woman in Virginia died last month after receiving the vaccine, but state health officials emphasized they do not know yet if the fatality was related to the federal pause.

According to The New York Times, nearly seven million people have received J&J shots, which are effective after one dose, and nine million more doses have been shipped nationwide. Six women between the ages of 18 and 48 developed a rare blood clot disorder within about two weeks of vaccination, and one woman died, the Times reported.

According to the Centers for Disease Control and Prevention’s public Vaccine Adverse Event Reporting System, a 45-year-old woman in Virginia died from a stroke-like syndrome in March, less than two weeks after receiving a J&J vaccine manufactured by Janssen Biotech Inc., a pharmaceutical company owned by Johnson & Johnson.

State vaccine coordinator Dr. Danny Avula said in a press call Tuesday afternoon that he has contacted the CDC and the FDA for clarification. VDH does not know if this incident is related to the J&J vaccine pause, spokespeople emphasized.

According to the CDC report, the woman in Virginia, who was in her 40s, went to the hospital March 17 complaining of a suddenly worsening headache, dry heaves and left-sided weakness. A CT scan revealed a brain hemorrhage. After being admitted, she was intubated “for worsening mental status.” After further decline, she was diagnosed as “brain dead” on March 18, the day she died. The CDC report does not confirm whether the death was caused by the vaccine, which she received March 6, and then began to feel ill six days later.

Avula’s statement earlier Tuesday did not address how long it would take for J&J vaccine appointments to be rescheduled, but some health districts and departments in Virginia have said they will give Pfizer and Moderna vaccines to people who had appointments this week to receive the Johnson & Johnson vaccine.

“We are closely monitoring the actions by the federal government to pause all Johnson & Johnson vaccinations while it investigates an extremely rare possible side effect,” Avula said in a statement. “In Virginia, we will cease all Johnson & Johnson vaccines until this investigation is complete. If you have an upcoming appointment for the Johnson & Johnson vaccine, you will be contacted to reschedule that appointment.

“This pause is reassuring in that it demonstrates that the systems that are in place to monitor vaccine safety are working. We look forward to a thorough review by federal health officials. Meantime, we will continue Virginia’s vaccine rollout at this time with the other two authorized vaccines, developed by Pfizer and Moderna.”

The Food and Drug Administration and the Centers for Disease Control and Prevention said in a joint statement that the agencies are recommending a pause in the vaccine’s use, and they will not be offering J&J shots at federal clinics. Other states, including Ohio and Virginia, have followed suit in the hours after the announcement, advising health practitioners in their states to stop using the vaccine for now.

“We are recommending a pause in the use of this vaccine out of an abundance of caution. Right now, these adverse events appear to be extremely rare,” read the statement from Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, and CDC Principal Deputy Director Dr. Anne Schuchat.

J&J’s vaccine ran into trouble earlier this year when a batch of 15 million doses had to be thrown out after it was discovered ingredients were incorrectly mixed at the Baltimore-based pharmaceutical plant Emergent BioSolutions.

Subscribe to Virginia Business.

Get our daily e-newsletter.

Related Stories

COVID roundup: Most of Va. is now in vaccine phase 2

NoVa, Peninsula, Hampton still in first phase, but will progress by Sunday

Virginia Business logo

Northam requests federal support to vaccinate federal employees

Maryland governor, D.C. mayor also sign letter to U.S. HHS, FEMA

Richmond Mayor Levar Stoney receives his COVID-19 vaccine shot at the Arthur Ashe Athletic Center in March 2021. Photo courtesy city of Richmond

COVID roundup: 28% of Va. population vaccinated

Restrictions to be eased April 1

Trending

13th annual Best Places to Work

Report: Air taxis could land Va. $16B in new biz by 2045

Morrissey’s Petersburg casino bill fails in Senate Finance

Magical moments

Cox expands Myers’ role to East Coast

Sponsored Stories

Working at Pinnacle Financial Partners

What Logistics issues will have the biggest impact on you in 2023?

In the New Year, Aim for Better Cybersecurity

4 innovative ways to create capacity

WHERE IS THE SUPPLY CHAIN WHEN YOU NEED IT?

P.A.I.N.T. Your Financial Mountain

5 Benefits of Treasury Management Services from Atlantic Union Bank

Blazing trails in the digital landscape

Advertisement

Advertisement

Trending

13th annual Best Places to Work

Report: Air taxis could land Va. $16B in new biz by 2045

Morrissey’s Petersburg casino bill fails in Senate Finance

Magical moments

Cox expands Myers’ role to East Coast

Sponsored Stories

Working at Pinnacle Financial Partners

What Logistics issues will have the biggest impact on you in 2023?

In the New Year, Aim for Better Cybersecurity

4 innovative ways to create capacity

WHERE IS THE SUPPLY CHAIN WHEN YOU NEED IT?

P.A.I.N.T. Your Financial Mountain

5 Benefits of Treasury Management Services from Atlantic Union Bank

Blazing trails in the digital landscape

Get Virginia Business directly on your tablet or in your mailbox!

Subscribe to Virginia Business

Advertisement

Advertisement

Footer Primary Menu

  • virginiabusiness.com
  • Subscribe
  • Advertise
  • About Us
  • Contact Us

Footer Secondary Menu

  • Industries
  • Regions
  • Reports
  • Company News
  • Events

Sign Up For Our Newsletter

Sign Up

LinkedIn Facebook Twitter Instagram Get Our App

Privacy Policy Cookie Policy

Footer Utility Menu

Copyright © 2023 Virginia Business. All rights reserved.

Site Maintained by TechArk